Galectin Therapeutics Inc.
DE ˙ DB ˙ US3632252025
1,88 € ↓ -0,05 (-2,59%)
2026-06-03
DEL PRIS
SecurityDE:PHPN / Galectin Therapeutics Inc.
InstitutionWealthspire Advisors, LLC
Latest Disclosed Ownership721,788 shares
Latest Disclosed Value $ 2,013,789
Wealthspire Advisors, LLC reports 19.90% increase in ownership of PHPN / Galectin Therapeutics Inc.

On May 1, 2026 - Wealthspire Advisors, LLC filed a 13F-HR form disclosing ownership of 721,788 shares of Galectin Therapeutics Inc. (DE:PHPN) valued at $1,616,805 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 601,973 shares of Galectin Therapeutics Inc.. This represents a change in shares of 19.90% during the quarter. The current value of the position is $1,356,961 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 721,788 119,815 19.90 2,014 -19.61 0.0158
2026-02-12 2025-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 601,973 122,455 25.54 2,504 23.35 0.0199
2025-11-14 2025-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 479,518 0 0.00 2,031 100.79 0.0106
2025-08-11 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 479,518 81,144 20.37 1,012 108.02 0.0057
2025-05-09 2025-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 398,374 0 0.00 486 -5.26 0.0029
2025-02-04 2024-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 398,374 0 0.00 514 -53.15 0.0051
2024-11-13 2024-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 398,374 0 0.00 1,096 21.67 0.0111
2024-08-08 2024-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 398,374 0 0.00 900 -5.46 0.0115
2024-05-06 2024-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 398,374 214,512 116.67 952 212.13 0.0127
2024-02-07 2023-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 183,862 0 0.00 305 -13.60 0.0043
2023-11-06 2023-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 183,862 0 0.00 353 33.71 0.0058
2023-08-01 2023-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 183,862 0 0.00 265 -31.61 0.0043
2023-05-09 2023-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 183,862 183,862 386 0.0066
2023-02-13 2022-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -17,355 -100.00 0 -100.00
2022-11-14 2022-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 17,355 0 0.00 28 21.74 0.0006
2022-08-09 2022-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 17,355 0 0.00 23 -17.86 0.0005
2022-05-09 2022-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 17,355 3,500 25.26 28 -3.45 0.0006
2022-02-14 2021-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,855 0 0.00 29 -46.30 0.0006
2021-11-15 2021-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,855 0 0.00 54 22.73 0.0011
2021-08-13 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,855 0 0.00 44 46.67 0.0012
2021-05-17 2021-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,855 0 0.00 30 -3.23 0.0007
2021-02-16 2020-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,855 0 0.00 31 -16.22 0.0009
2020-11-16 2020-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,855 0 0.00 37 -11.90 0.0022
2020-08-14 2020-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,855 0 0.00 42 55.56 0.0029
2020-05-12 2020-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,855 0 0.00 27 -32.50 0.0011
2020-02-14 2019-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,855 0 0.00 40 -21.57 0.0029
2019-11-12 2019-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,855 13,855 51 0.0042
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.